AstraZeneca

Explore the latest insights on AstraZeneca and its impact on China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of AstraZeneca’s developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.
Explore the latest insights on AstraZeneca and its impact on China's pharmaceutical industry. Fineline Info & Tech delivers reliable data, news, and intelligence to help you navigate the complexities of AstraZeneca's developments with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

AbbVie Launches Epkinly (Epcoritamab) in China – First Bispecific Antibody Approved by NMPA for Relapsed/Refractory Follicular Lymphoma in the Second‑Line and Beyond
CompanyDrug

AbbVie Launches Epkinly (Epcoritamab) in China – First Bispecific Antibody Approved by NMPA for Relapsed/Refractory Follicular Lymphoma in the Second‑Line and Beyond

AbbVie Inc. (NYSE: ABBV) announced the official launch in China of Epkinly (epcoritamab), a CD3×CD20 bispecific antibody, for the treatment of adult patients with relapsed or refractory (R/R) follicular lymphoma…

Zymeworks Inks Global License and Collaboration Agreement with Roche for ZW209 – Up to USD 813 Million Deal for Novel DLL3‑Targeting Trispecific T Cell Engager

Zymeworks Inks Global License and Collaboration Agreement with Roche for ZW209 – Up to USD 813 Million Deal for Novel DLL3‑Targeting Trispecific T Cell Engager

Bio‑Thera's BAT2306 Becomes World's First Secukinumab Biosimilar with NMPA Approval Across Psoriasis, Ankylosing Spondylitis and Psoriatic Arthritis

Bio‑Thera’s BAT2306 Becomes World’s First Secukinumab Biosimilar with NMPA Approval Across Psoriasis, Ankylosing Spondylitis and Psoriatic Arthritis

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Kelun-Biotech’s SKB264 Approved for Phase II Study in EGFR-Mutant NSCLC

CompanyDrug

AstraZeneca’s Nexium Approved by NMPA for Adolescent GERD Treatment

CompanyDeals

Luye Pharma Group Hands Over Seroquel Distribution Rights to DCH Auriga in Singapore

CompanyDeals

GenAssist Therapeutics Secures Series A Funding for Gene Therapy Development

CompanyDrug

Enhertu Confirmed as New Standard of Care for Breast Cancer in Phase III Study

CompanyDeals

ZSHK Laboratories Raises RMB 100 Million in Series B Financing Round

Company

Taizhou-Wuxi-Lianyungang Biomedicine Hub Launched at China Medical Expo

CompanyDrug

Peru Approves BMS’s Reblozyl and BeiGene’s Brukinsa

Show More